Actually, the most likely scenario is that AR activation or blockade could serve as adjunctive therapy in chemotherapeutic and immunotherapeutic (even chemoradiation/radiotherapeutic) approaches to combat a wide variety of cancers. The gene discussed is AR; the disease is cancer.